90 related articles for article (PubMed ID: 26898119)
1. Serum cytokine profile in patients with breast cancer.
Li L; Chen L; Zhang W; Liao Y; Chen J; Shi Y; Luo S
Cytokine; 2017 Jan; 89():173-178. PubMed ID: 26898119
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum visfatin levels and prognosis of breast cancer among Chinese women.
Li XY; Tang SH; Zhou XC; Ye YH; Xu XQ; Li RZ
Peptides; 2014 Jan; 51():86-90. PubMed ID: 24269296
[TBL] [Abstract][Full Text] [Related]
3. Influence of Circulating Tumour Cells on Production of IL-1α, IL-1β and IL-12 in Sera of Patients with Primary Diagnosis of Breast Cancer Before Treatment.
Vilsmaier T; Rack B; König A; Friese K; Janni W; Jeschke U; Weissenbacher T;
Anticancer Res; 2016 Oct; 36(10):5227-5236. PubMed ID: 27798883
[TBL] [Abstract][Full Text] [Related]
4. Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.
Dehqanzada ZA; Storrer CE; Hueman MT; Foley RJ; Harris KA; Jama YH; Shriver CD; Ponniah S; Peoples GE
Oncol Rep; 2007 Mar; 17(3):687-94. PubMed ID: 17273752
[TBL] [Abstract][Full Text] [Related]
5. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.
Vazquez-Martin A; Colomer R; Menendez JA
Eur J Cancer; 2007 May; 43(7):1117-24. PubMed ID: 17379503
[TBL] [Abstract][Full Text] [Related]
6. Cytokine comparisons between women with breast cancer and women with a negative breast biopsy.
Lyon DE; McCain NL; Walter J; Schubert C
Nurs Res; 2008; 57(1):51-8. PubMed ID: 18091292
[TBL] [Abstract][Full Text] [Related]
7. Cytokine profiling in serum-derived exosomes isolated by different methods.
Jung HH; Kim JY; Lim JE; Im YH
Sci Rep; 2020 Aug; 10(1):14069. PubMed ID: 32826923
[TBL] [Abstract][Full Text] [Related]
8. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
Chi Y; Yao L; Hu X; Huang S; Huang N; Li S; Shao Z; Wu J
Oncotarget; 2016 Mar; 7(12):14951-62. PubMed ID: 26908452
[TBL] [Abstract][Full Text] [Related]
9. Insulin use, adipokine profiles and breast cancer prognosis.
Wintrob ZA; Hammel JP; Khoury T; Nimako GK; Fu HW; Fayazi ZS; Gaile DP; Forrest A; Ceacareanu AC
Cytokine; 2017 Jan; 89():45-61. PubMed ID: 27914795
[TBL] [Abstract][Full Text] [Related]
10. Changes of cytokines and thyroid function in patients with recurrent breast cancer.
Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
Anticancer Res; 1997; 17(1B):695-9. PubMed ID: 9066604
[TBL] [Abstract][Full Text] [Related]
11. The Association of Serum IL-33 and sST2 with Breast Cancer.
Yang ZP; Ling DY; Xie YH; Wu WX; Li JR; Jiang J; Zheng JL; Fan YH; Zhang Y
Dis Markers; 2015; 2015():516895. PubMed ID: 26456994
[TBL] [Abstract][Full Text] [Related]
12. Extensive serum cytokine analysis in patients with prostate cancer.
Gong D; Wang Y; Wang Y; Chen X; Chen S; Wang R; Liu L; Duan C; Luo S
Cytokine; 2020 Jan; 125():154810. PubMed ID: 31430659
[TBL] [Abstract][Full Text] [Related]
13. Identification of mammaglobin as a novel serum marker for breast cancer.
Bernstein JL; Godbold JH; Raptis G; Watson MA; Levinson B; Aaronson SA; Fleming TP
Clin Cancer Res; 2005 Sep; 11(18):6528-35. PubMed ID: 16166429
[TBL] [Abstract][Full Text] [Related]
14. Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery.
Cash E; Sephton SE; Chagpar AB; Spiegel D; Rebholz WN; Zimmaro LA; Tillie JM; Dhabhar FS
Brain Behav Immun; 2015 Aug; 48():102-14. PubMed ID: 25728235
[TBL] [Abstract][Full Text] [Related]
15. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
Meenakshi A; Kumar RS; Kumar NS
J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
17. Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer.
Aharinejad S; Salama M; Paulus P; Zins K; Berger A; Singer CF
Endocr Relat Cancer; 2013 Dec; 20(6):777-83. PubMed ID: 24016870
[TBL] [Abstract][Full Text] [Related]
18. Increased interleukin-35 expression in tumor-infiltrating lymphocytes correlates with poor prognosis in patients with breast cancer.
Zhao Z; Chen X; Hao S; Jia R; Wang N; Chen S; Li M; Wang C; Mao H
Cytokine; 2017 Jan; 89():76-81. PubMed ID: 27681506
[TBL] [Abstract][Full Text] [Related]
19. Biologic markers and breast cancer: a multiparametric study--1. Increased serum protein levels.
Lamoureux G; Mandeville R; Poisson R; Legault-Poisson S; Jolicoeur R
Cancer; 1982 Feb; 49(3):502-12. PubMed ID: 6977405
[TBL] [Abstract][Full Text] [Related]
20. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
Mangé A; Dimitrakopoulos L; Soosaipillai A; Coopman P; Diamandis EP; Solassol J
J Proteomics; 2016 Jun; 142():114-21. PubMed ID: 27168011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
